Ryman Healthcare Limited Stock Probability of Future Pink Sheet Price Finishing Under 2.61

RHCGF Stock  USD 2.61  0.00  0.00%   
Ryman Healthcare's future price is the expected price of Ryman Healthcare instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Ryman Healthcare Limited performance during a given time horizon utilizing its historical volatility. Check out Ryman Healthcare Backtesting, Ryman Healthcare Valuation, Ryman Healthcare Correlation, Ryman Healthcare Hype Analysis, Ryman Healthcare Volatility, Ryman Healthcare History as well as Ryman Healthcare Performance.
  
Please specify Ryman Healthcare's target price for which you would like Ryman Healthcare odds to be computed.

Ryman Healthcare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ryman Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ryman Healthcare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ryman Healthcare generated a negative expected return over the last 90 days
Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity.
About 17.0% of Ryman Healthcare outstanding shares are owned by corporate insiders

Ryman Healthcare Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ryman Pink Sheet often depends not only on the future outlook of the current and potential Ryman Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ryman Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding500 M
Dividends Paid112 M

Ryman Healthcare Technical Analysis

Ryman Healthcare's future price can be derived by breaking down and analyzing its technical indicators over time. Ryman Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ryman Healthcare Limited. In general, you should focus on analyzing Ryman Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Ryman Healthcare Predictive Forecast Models

Ryman Healthcare's time-series forecasting models is one of many Ryman Healthcare's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ryman Healthcare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Ryman Healthcare

Checking the ongoing alerts about Ryman Healthcare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ryman Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ryman Healthcare generated a negative expected return over the last 90 days
Ryman Healthcare Limited has accumulated 2.58 B in total debt with debt to equity ratio (D/E) of 0.76, which is about average as compared to similar companies. Ryman Healthcare has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Ryman Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Ryman Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ryman Healthcare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ryman to invest in growth at high rates of return. When we think about Ryman Healthcare's use of debt, we should always consider it together with cash and equity.
About 17.0% of Ryman Healthcare outstanding shares are owned by corporate insiders

Other Information on Investing in Ryman Pink Sheet

Ryman Healthcare financial ratios help investors to determine whether Ryman Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.